GLP-1 medications like Mounjaro (tirzepatide) and Wegovy (semaglutide) reduce hunger and cravings, helping us lose weight by eating fewer calories
References Urva S, Coskun T, Loh MT, et al
Although GLP-1 medications can lead to significant weight loss, they don't work for everyone, Dr
Vyvanse tends to cause fewer mood swings, crashes, and rebound irritability than Adderall because of its slower, steadier onset, making it a potentially better fit for people with anxiety or emotional sensitivity, while Adderall's faster onset and flexible dosing formats may suit those who need quicker symptom control or more scheduling flexibility
Potential Benefits: Significant weight loss (mean 1015% body weight reduction in clinical trials at 2.4 mg weekly dose) when combined with lifestyle modifications [1] [5]
The Future of Weight Loss Medications: Research and Innovation The future of weight loss medications is promising, with ongoing research driving innovation